AVIDITE
Live / Allowed — Third extension granted (statement of use) (as of 24 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Feb 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97284741
- Mark type
- Word mark
- Filed
- 25 Feb 2022
- Published for opposition
- 12 Nov 2024
- Attorney of record
- Samantha C. Markley
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes
- Class 005 — Pharmaceuticals: Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical diagnostic use
- Class 009 — Scientific and electric apparatus: Computer systems, namely, computer hardware, downloadable computer software and associated downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers
- Class 010 — Medical apparatus: Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers
- Class 042 — Scientific and technological services: Providing temporary use of online non-downloadable computer software and non-downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; providing temporary use of online non-downloadable computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes
Owner
- Element Biosciences, Inc., San Diego, CA, US
- Element Biosciences, Inc., San Diego, CA, US
Prosecution history
- 25 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2026 — SOU EXTENSION 3 GRANTED
- 24 Jun 2026 — SOU EXTENSION 3 FILED
- 24 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 20 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Dec 2025 — SOU EXTENSION 2 GRANTED
- 19 Dec 2025 — SOU EXTENSION 2 FILED
- 19 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2025 — SOU EXTENSION 1 GRANTED
- 17 Jun 2025 — SOU EXTENSION 1 FILED
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Nov 2024 — PUBLISHED FOR OPPOSITION